OsteoarthritisNCT06228612
Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis
A study testing vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS) in people with Osteoarthritis, run by Mansoura University at 1 site in Egypt.
Trial summary
The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Osteoarthritis
- What is being tested?
- vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 42 participants
- Where
- 1 siteEgypt
- Study dates
- 20 Jan 2021to 17 Nov 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.
Who cannot join
- Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: How Far Are Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis? A Randomized Clinical Trial.
The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis.
Read the detailed description
Study design and patients´ selection:
This prospective parallel randomized clinical trial included patients diagnosed with TMJ osteoarthritis. All Patients were collected from the TMD clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University. The study was approved by the local ethics committee with ethical approval number A12060922. All patients were aware of the treatment procedures and signed informed consents for their participation. Patients were recruited and data collection was performed between . CONSORT guidelines were followed when approperiate19 Inclusion and exclusion criteria were defined prior to the beginning of the study. Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.
Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.
Sample size calculation:
Sample size calculation was performed by using G*Power software (version 3.1.9.7) based on previous study by El-Shaheed et al.21 A medium effect size (f = 0.25) for interaction effect of treatment group and time on quantitative outcomes (amount of mouth opening in mm, temporo-mandibular joint palpation and VAS score for pain) and a large effect size (f = 0.4) for main group effect on these outcome measures were hypothesised. Based on these assumptions, a total sample size of 42 (14 in each treatment group) achieved 83% power to detect a large effect size (f = 0.4) with 0.05 α-error probability using F test anova: Repeated measures, between factors for three groups and five measurements with a .5 correlation between measurements.
Patients' randomization:
Patients who are eligible in this study after screening phase and who agree to sign the consent form were randomly assigned to grouping. Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.
Intervention:
The treatments were applied by an experienced dentist, with the necessary training in TMD specialty.
For group (I) (VT group), vacuum therapy was applied over the TMJ. Before intervention, all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools. The cup can be fixed by means of fixation gel () before application of the cup as hair might interfere with the cup peripheral seal. Dry vacuum therapy was accomplished by application of constant negative pressure of 300 mbar (which is equal to two suctions) using the manual suction pump through the suction cup over the TMJ region for 5 minutes22 (Fig.1). Whether any extra oral muscle showed pain, vacuum therapy application was performed using the same protocol. After completing the procedures, an anti-septic solution was placed over the vacuum application site (sites). All patients in this group were treated one session per week for four successive weeks (Fig.2).
For group (II) (ST group), A maxillary stabilization splint (MSS) was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth. The occlusal contact of the splint was adjusted to provide even simultaneous contact with the opposing mandibular cusps in the treatment position. the mandibular canines provide laterotrusive guidance in lateral exertions (canine guidance), and mandibular anterior teeth provide anterior contact and posterior disocclusion (anterior guidance). After processing, the splint was fitted on the maxillary arch and adjusted if needed (Fig.3). Patients were advised to wear it 12 hours per day for six months. Patients were recalled regularly for occlusal readjustment of the splint.
For group (III) (VT+SST), both VT and SST were started at the same day. Procedures were the same as in group I and II.
Collagen hydrolysate
Patients' evaluation:
Patients' evaluation was performed by an experienced independent researcher who did not participate in other procedures in this study and was blinded to all intervention groups.
I- Clinical evaluation:
Patients were evaluated regarding their TMJ signs and symptoms at base line (T0), one week (Tw), one month (T1), three months (T3), and six months (T6):
- Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.
- The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain).
- TMJ tenderness on palpation was assessed by Verbal Rating Scale (VRS) using firm and constant pressure of half kg lasted two seconds over the condyle in front of the tragus. The degree of joint tenderness was extended from 0 to 3 (0: no; 1: slight; 2: moderate; 3: severe).
- Joint sound was detected using stethoscope
- Change perception was assessed at Tw, T1, T3, and T6 with the Patient Global Impression of Change Scale (PGICS) which evaluates the change perceived by the patients after treatment. This scale has seven affirmations depicting a patient's rating of overall improvement (1 "very much improved", 2 "much improved", 3 "minimally improved", 4 "no change", 5 "minimally worse", 6 "much worse", or 7 "very much worse").
- Any side effects from either treatments also had been reported.
- Conditions
- Osteoarthritis
- Being tested
- vacuum therapy, maxillary stabilization splint (MSS), vacuum therapy VT and maxillary stabilization splint (MSS)
- Keywords
- TMJ, osteoarthritis, vacuum, stabilization splint.
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
vacuum therapyDevice
vacuum therapy :all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools.
maxillary stabilization splint (MSS)Device
maxillary stabilization splint (MSS): was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth.
vacuum therapy VT and maxillary stabilization splint (MSS)Device
vacuum therapy VT and maxillary stabilization splint (MSS): both Basic vacuum therapy and maxillary stabilization splint :Procedures were the same as in group I and II.
| Study group | Role | What they receive |
|---|---|---|
| group I:vacuum therapy | Active comparator | group I:vacuum therapy VT:patients who were diagnosed with TMJ osteoarthritis. The patients received Isolated vacuum therapy VT Receives: Device: vacuum therapy |
| group II: maxillary stabilization splint (MSS) | Active comparator | group II, patients who were diagnosed with TMJ osteoarthritis. The patients received stabilization splint therapy (STT) Receives: Device: maxillary stabilization splint (MSS) |
| group III: vacuum therapy VT and maxillary stabilization splint (MSS) | Active comparator | group III: patients who were diagnosed with TMJ osteoarthritis. The patients received combined VT and SST. Receives: Device: vacuum therapy VT and maxillary stabilization splint (MSS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maximum comfortable mouth opening (MCO),
Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.
Measured: 6 months
Secondary outcomes (1)
visual analogue scale (VAS),
The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain).
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jan 2024
- Study start20 Jan 2021
- Primary completion3 Dec 2022
- Study completion17 Nov 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 42 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Fatma Ahmad EL-Waseef, Associate professor, Principal investigator, Faculty of Dentistry.Mansoura University,Prosthodontics Departement
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06228612
- Sponsor's protocol ID
- A12060922
- Status last verified
- Dec 2020
- First submitted
- 13 Dec 2023
- Last updated
- 29 Jan 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- How Far Are Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis? A Randomized Clinical Trial.
- ClinicalTrials.gov ID
- NCT06228612
- Acronym / sponsor ID
- A12060922
- Conditions
- Osteoarthritis
- Keywords
- TMJ, osteoarthritis, vacuum, stabilization splint.
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 42 participants (actual)
- Lead sponsor
- Mansoura UniversityUniversity, hospital or other
- Study start
- 20 Jan 2021 (actual)
- Primary completion
- 3 Dec 2022 (actual)
- Study completion
- 17 Nov 2023 (actual)
- First posted
- 29 Jan 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis.
Detailed description
Study design and patients´ selection:
This prospective parallel randomized clinical trial included patients diagnosed with TMJ osteoarthritis. All Patients were collected from the TMD clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University. The study was approved by the local ethics committee with ethical approval number A12060922. All patients were aware of the treatment procedures and signed informed consents for their participation. Patients were recruited and data collection was performed between . CONSORT guidelines were followed when approperiate19 Inclusion and exclusion criteria were defined prior to the beginning of the study. Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.
Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.
Sample size calculation:
Sample size calculation was performed by using G*Power software (version 3.1.9.7) based on previous study by El-Shaheed et al.21 A medium effect size (f = 0.25) for interaction effect of treatment group and time on quantitative outcomes (amount of mouth opening in mm, temporo-mandibular joint palpation and VAS score for pain) and a large effect size (f = 0.4) for main group effect on these outcome measures were hypothesised. Based on these assumptions, a total sample size of 42 (14 in each treatment group) achieved 83% power to detect a large effect size (f = 0.4) with 0.05 α-error probability using F test anova: Repeated measures, between factors for three groups and five measurements with a .5 correlation between measurements.
Patients' randomization:
Patients who are eligible in this study after screening phase and who agree to sign the consent form were randomly assigned to grouping. Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.
Intervention:
The treatments were applied by an experienced dentist, with the necessary training in TMD specialty.
For group (I) (VT group), vacuum therapy was applied over the TMJ. Before intervention, all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools. The cup can be fixed by means of fixation gel () before application of the cup as hair might interfere with the cup peripheral seal. Dry vacuum therapy was accomplished by application of constant negative pressure of 300 mbar (which is equal to two suctions) using the manual suction pump through the suction cup over the TMJ region for 5 minutes22 (Fig.1). Whether any extra oral muscle showed pain, vacuum therapy application was performed using the same protocol. After completing the procedures, an anti-septic solution was placed over the vacuum application site (sites). All patients in this group were treated one session per week for four successive weeks (Fig.2).
For group (II) (ST group), A maxillary stabilization splint (MSS) was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth. The occlusal contact of the splint was adjusted to provide even simultaneous contact with the opposing mandibular cusps in the treatment position. the mandibular canines provide laterotrusive guidance in lateral exertions (canine guidance), and mandibular anterior teeth provide anterior contact and posterior disocclusion (anterior guidance). After processing, the splint was fitted on the maxillary arch and adjusted if needed (Fig.3). Patients were advised to wear it 12 hours per day for six months. Patients were recalled regularly for occlusal readjustment of the splint.
For group (III) (VT+SST), both VT and SST were started at the same day. Procedures were the same as in group I and II.
Collagen hydrolysate
Patients' evaluation:
Patients' evaluation was performed by an experienced independent researcher who did not participate in other procedures in this study and was blinded to all intervention groups.
I- Clinical evaluation:
Patients were evaluated regarding their TMJ signs and symptoms at base line (T0), one week (Tw), one month (T1), three months (T3), and six months (T6):
- Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.
- The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain).
- TMJ tenderness on palpation was assessed by Verbal Rating Scale (VRS) using firm and constant pressure of half kg lasted two seconds over the condyle in front of the tragus. The degree of joint tenderness was extended from 0 to 3 (0: no; 1: slight; 2: moderate; 3: severe).
- Joint sound was detected using stethoscope
- Change perception was assessed at Tw, T1, T3, and T6 with the Patient Global Impression of Change Scale (PGICS) which evaluates the change perceived by the patients after treatment. This scale has seven affirmations depicting a patient's rating of overall improvement (1 "very much improved", 2 "much improved", 3 "minimally improved", 4 "no change", 5 "minimally worse", 6 "much worse", or 7 "very much worse").
- Any side effects from either treatments also had been reported.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 3
- Model description
- Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.
| Arm | Type | Receives |
|---|---|---|
| group I:vacuum therapy | Active comparator | Device: vacuum therapygroup I:vacuum therapy VT:patients who were diagnosed with TMJ osteoarthritis. The patients received Isolated vacuum therapy VT |
| group II: maxillary stabilization splint (MSS) | Active comparator | Device: maxillary stabilization splint (MSS)group II, patients who were diagnosed with TMJ osteoarthritis. The patients received stabilization splint therapy (STT) |
| group III: vacuum therapy VT and maxillary stabilization splint (MSS) | Active comparator | Device: vacuum therapy VT and maxillary stabilization splint (MSS)group III: patients who were diagnosed with TMJ osteoarthritis. The patients received combined VT and SST. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.
Key exclusion criteria (1 listed)
- Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| vacuum therapyvacuum therapy :all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools. | Device | group I:vacuum therapy |
| maxillary stabilization splint (MSS)maxillary stabilization splint (MSS): was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth. | Device | group II: maxillary stabilization splint (MSS) |
| vacuum therapy VT and maxillary stabilization splint (MSS)vacuum therapy VT and maxillary stabilization splint (MSS): both Basic vacuum therapy and maxillary stabilization splint :Procedures were the same as in group I and II. | Device | group III: vacuum therapy VT and maxillary stabilization splint (MSS) |
Primary outcome
Maximum comfortable mouth opening (MCO),
Time frame: 6 months
Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.
1 secondary outcome
visual analogue scale (VAS),
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2024.
- Individual participant dataSharing planned: No
Related trials for Osteoarthritis
Recruiting
Outpatient Physiotherapy vs. mHealth Exercise and Self-Management for Knee Osteoarthritis (MOKneeTOR)
Knee Osteoarthristis
Not yet recruiting
Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis
Knee Osteoarthritis
Recruiting
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
Osteoarthritis, Knee
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Not yet recruiting
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis.(BFR)
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Fatma Ahmad EL-Waseef, Associate professor principal investigator
Faculty of Dentistry.Mansoura University,Prosthodontics Departement
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS) in people with Osteoarthritis, run by Mansoura University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maximum comfortable mouth opening (MCO), (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2024.